Foundry Partners’s Zimmer Biomet ZBH Stock Holding History

Foundry Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$583K	Sell	5,154 -302	-6%	-$32.3K	0.03%	226
2024 Q4	$576K	Sell	5,456 -103	-2%	-$11.1K	0.03%	234
2024 Q3	$600K	Buy	5,559 +322	+6%	+$35.1K	0.03%	238
2024 Q2	$568K	Buy	+5,237	New	+$617K	0.03%	226
2021 Q3	–	Sell	-80,824	Closed	-$12.6M	–	395
2021 Q2	$12.6M	Sell	80,824 -1,468	-2%	-$238K	0.43%	89
2021 Q1	$12.8M	Sell	82,292 -12,674	-13%	-$1.96M	0.42%	89
2020 Q4	$14.2M	Sell	94,966 -3,568	-4%	-$504K	0.56%	52
2020 Q3	$13M	Buy	+98,534	New	+$12.9M	0.63%	45
2020 Q1	–	Sell	-1,670	Closed	-$243K	–	424
2019 Q4	$243K	Buy	+1,670	New	+$231K	0.01%	381
2014 Q2	–	Sell	-5,536	Closed	-$508K	–	295
2014 Q1	$508K	Sell	5,536 -1,628	-23%	-$150K	0.05%	220
2013 Q4	$648K	Buy	+7,164	New	+$620K	0.06%	215

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Foundry Partners's ZBH Position: Q1 2025 in Review

Foundry Partners reduced its Zimmer Biomet (ZBH) stake by 5.5% in Q1 2025, selling an estimated $32.3K and leaving 5,154 shares worth $583K. The position accounts for 0.03% of the portfolio, ranked #226.

Foundry Partners first reported a position in ZBH in Q4 2013 and has held it in 11 quarters since. The position peaked at $14.2M in Q4 2020. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

Foundry Partners held 5,154 shares of Zimmer Biomet worth $583K as of Q1 2025.
Foundry Partners sold 302 Zimmer Biomet shares in Q1 2025, an estimated $32.3K.
Zimmer Biomet made up 0.03% of Foundry Partners's portfolio in Q1 2025, its #226 holding.
Foundry Partners first reported a position in Zimmer Biomet in Q4 2013 and has held it in 11 quarters since.
Foundry Partners's Zimmer Biomet position peaked at $14.2M in Q4 2020.
1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on Foundry Partners's 13F filing for Q1 2025, filed 5 May 2025.